Insider Transactions Reported by 13 Insiders of Aldeyra Therapeutics, Inc.

Symbol
ALDX on Nasdaq
Location
Lexington, MA

Insiders trading volume in the past year

Aldeyra Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
PERCEPTIVE ADVISORS LLC 10%+ Owner $27,829,793 03 Apr 2025
Todd C. Brady President and CEO, Director $4,487,459 04 Mar 2025
Stephen Machatha Chief Development Officer $1,142,641 -$113,713 -9.1% 11 Aug 2025
Bruce Greenberg Interim Chief Financial Officer $598,583 12 Aug 2024
Joshua Reed Chief Financial Officer $478,196 30 Mar 2022
Michael Alfieri Principal Financial Officer $13,250 +$13,250 13 Aug 2025
Nancy Miller-Rich Director $9,340 10 Jun 2025
DOUGLAS RICHARD Director 10 Jun 2025
MARTIN JOYCE Director 10 Jun 2025
Neal Walker Director 10 Jun 2025
Gary Phillips Director 10 Jun 2025
William D. Clark Director 17 Apr 2025
Ben Bronstein Director 10 Jun 2025

Recent Insider Transactions by Companies or Individuals for Aldeyra Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.